Table 3.
Characteristics of the patient who had vaccine-related side effects.
| Variable | Patient-reported Side effect N= 66 (N/ %) | test of significance | p |
|---|---|---|---|
| Age: | |||
| • Mean± SD • Median (min-max) |
34.758±11.906 33.5 (16-67) |
U=1157.0 | 0.049* |
| Gender: | |||
| • Male • Female |
22(33.3) 44(66.7) |
X2 =4.41 | 0.036* |
| Social status: | |||
| • Single • Married • Divorced • Widow |
30(45.5) 24(36.6) 9(13.6) 3(4.5) |
X2 =4.28 | 0.232 |
| Job: | |||
| • Full time • Part-time • Student • Retired • Jobless • Self-employed |
27(40.9) 5(7.6) 11(16.7) 6(9.1) 16(24.2) 1(1.5) |
X2 =8.860 | 0.155 |
| Epilepsy duration: | |||
| • Two years or less • More than two years |
7(10.6) 59(89.4) |
t=1.731 | 0.086 |
| Epilepsy type: | |||
| • Generalized tonic-clonic • Focal with loss of awareness • Focal without loss of awareness • Absence • myoclonus |
20(30.3) 14(21.2) 15(22.7) 8(12.1) 9(13.6) |
X2=3.850 | 0.517 |
| ASMs: | |||
| • monotherapy • polytherapy |
24(36.4) 42(63.6) |
t=2.918 | 0.004* |